The correlation between KRAS and TP53 gene mutations and early growth of pulmonary nodules

The purpose of this study is to investigate whether gene mutations can lead to the growth of malignant pulmonary nodules. Retrospective analysis was conducted on patients with pulmonary nodules at Hebei Provincial People's Hospital, collecting basic clinical information such as gender, age, BMI...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiothoracic surgery Vol. 19; no. 1; pp. 376 - 7
Main Authors: Zhao, Bin, Li, Bin, Guo, Haoxin, Zhao, Qingtao, Zhang, Xiaopeng, Zhao, Huanfen, Xue, Wenfei, Li, Wei, Duan, Guochen, Xu, Shun
Format: Journal Article
Language:English
Published: England BioMed Central Ltd 26-06-2024
BioMed Central
BMC
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this study is to investigate whether gene mutations can lead to the growth of malignant pulmonary nodules. Retrospective analysis was conducted on patients with pulmonary nodules at Hebei Provincial People's Hospital, collecting basic clinical information such as gender, age, BMI, and hematological indicators. According to the inclusion and exclusion criteria, 85 patients with malignant pulmonary nodules were selected for screening, and gene mutation testing was performed on all patient tissues to explore the relationship between gene mutations and the growth of malignant pulmonary nodules. There is a correlation between KRAS and TP53 gene mutations and the growth of pulmonary nodules (P < 0.05), while there is a correlation between KRAS and TP53 gene mutations and the growth of pulmonary nodules in the subgroup of invasive malignant pulmonary nodules (P < 0.05). Mutations in the TP53 gene can lead to the growth of malignant pulmonary nodules and are correlated with the degree of invasion of malignant pulmonary nodules.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1749-8090
1749-8090
DOI:10.1186/s13019-024-02927-0